The current price of SSYS is $6.11 — it has decreased by 10.41% since the previous close. Data as of Nov 5, 2026.
SSYS is down 11.83% over the past week, down 28.79% over the past month and down 37.97% over the past year. The price is below its 200-day moving average of $8.62.
Analysts' average 12-month price target for SSYS is $12.50, which implies 104.58% upside from the current price. Individual estimates range from $11.00 to $14.00.
Of the 4 analysts covering Stratasys Ltd., 1 rates it a strong buy, 2 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Stratasys Ltd. has a market capitalization of $538.19M. The company belongs to the Technology sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Stratasys Ltd. posted earnings of $0.03 per share against an estimate of $0.0075, beating expectations by 300.00%. Upcoming reports are listed in the earnings calendar.
Stratasys Ltd. reported revenue of $137.61M in its most recent quarter, which has decreased by 0.35% compared with the same quarter a year earlier. Analysts had expected $138.48M.
Stratasys Ltd. has not paid any dividends over the past year.
Companies most comparable to Stratasys Ltd. include Proto Labs, Inc., 3D Systems Corporation, Materialise N.V., Nano Dimension Ltd. and Velo3D, Inc.
In the latest trading session SSYS moved between $6.08 and $6.75, a range of 11.05% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Stratasys Ltd. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks SSYS has traded between $6.08 and $12.24. The current price is 50.08% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.